- Home
- HMY vs HALO Comparison
HMY vs HALO Comparison
Compare HMY & HALO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HMY | HALO |
|---|---|---|
| Founded | 1950 | 1998 |
| Country | South Africa | United States |
| Employees | N/A | N/A |
| Industry | Precious Metals | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.4B | 7.4B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | HMY | HALO |
|---|---|---|
| Price | $21.75 | $68.77 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 2 | 12 |
| Target Price | $16.00 | ★ $73.33 |
| AVG Volume (30 Days) | ★ 3.8M | 2.3M |
| Earning Date | 01-01-0001 | 11-03-2025 |
| Dividend Yield | ★ 0.77% | N/A |
| EPS Growth | ★ 67.74 | 56.68 |
| EPS | 1.29 | ★ 4.74 |
| Revenue | ★ $4,161,584,110.00 | $1,242,852,000.00 |
| Revenue This Year | $40.10 | $34.83 |
| Revenue Next Year | $14.83 | $24.84 |
| P/E Ratio | $16.74 | ★ $14.54 |
| Revenue Growth | 20.39 | ★ 31.19 |
| 52 Week Low | $7.97 | $47.00 |
| 52 Week High | $22.25 | $79.50 |
Technical Indicators
Market Signals| Indicator | HMY | HALO |
|---|---|---|
| Relative Strength Index (RSI) | 67.32 | 58.75 |
| Support Level | $21.22 | $61.23 |
| Resistance Level | $21.96 | $69.28 |
| Average True Range (ATR) | 0.78 | 1.69 |
| MACD | 0.12 | 0.69 |
| Stochastic Oscillator | 92.89 | 93.54 |
Price Performance
Historical ComparisonAbout HMY Harmony Gold Mining Company Limited
Harmony Gold Mining Co Ltd is a gold mining and exploration company having operations in South Africa and Papua New Guinea (PNG). Its projects include Bambanani, Joel, Masimong, Phakisa, Target 1, Tshepong, Unisel, Doornkop, and Kusasalethu. The group's segments are Tshepong Operations, Bambanani, Joel, Doornkop, Moab Khotsong, Hidden Valley, Target 1, Kusasalethu, Masimong, Unisel, and all other surface operations.
About HALO Halozyme Therapeutics Inc.
Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.